McKesson (FRA:MCK) Payments of Debt: €-9,000 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MCK McKesson Corp FRA:MCK
84 GF Score
Price €728.40
GF Value €675.90
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Payments of Debt?

McKesson FRA:MCK +5.69% 84 Payments of Debt is €-9,000 Mil as of Mar. 2026. GuruFocus rates FRA:MCK with a GF Score™ of 84/100 and a GF Value™ of €675.90 (Fairly Valued). The stock has 2 warning signs investors should review.

McKesson's Payments of Debt for the three months ended in Mar. 2026 was €-6,038 Mil.

McKesson's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €-9,000 Mil.

McKesson Payments of Debt Related Terms

McKesson Payments of Debt Historical Data

* Premium members only.

The historical data trend for McKesson's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McKesson Payments of Debt Chart

McKesson Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11,658.72 -9,082.22 -19,227.08 -14,434.63 -9,042.71

McKesson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,665.63 0.00 -1,940.00 -1,022.24 -6,037.70
FRA:MCK
84GF Score
McKesson Corp FRA:MCK
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

McKesson Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-9,000 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €-9,000 Mil mean?
McKesson (FRA:MCK) has a Payments of Debt of €-9,000 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on McKesson and its competitors.
Is McKesson's Payments of Debt too high?
McKesson's current Payments of Debt is €-9,000 Mil. Overall, McKesson has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Payments of Debt compare to CAH and COR?
McKesson's Payments of Debt of €-9,000 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Distribution company?
A good Payments of Debt depends on the Medical Distribution industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on McKesson and its competitors. McKesson's current Payments of Debt is €-9,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (FRA:MCK) is currently considered Fairly Valued. The stock's GF Value™ is €675.90, compared to a current price of €728.40 — trading 7.8% above its estimated fair value. The current Payments of Debt is €-9,000 Mil. McKesson's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For McKesson (FRA:MCK), the current Payments of Debt is €-9,000 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McKesson (FRA:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be overvalued. The current stock price of €728.40 is trading 7.8% above its estimated GF Value™ of €675.90. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for FRA:MCK:

  • Payments of Debt: €-9,000 Mil
  • GF Value™: €675.90 vs. price of €728.40 (7.8% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the FRA:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
84GF Score

Get the complete analysis for FRA:MCK

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€728.40
Price
€675.90
GF Value